Valganciclovir, sold under the brand name Valcyte among others, is an antiviral medication used to treat cytomegalovirus (CMV) infection in those with HIV/AIDS or following organ transplant. It is often used long term as it only suppresses rather than cures the infection.[2] Valganciclovir is taken by mouth.Common side effects include abdominal pain, headaches, trouble sleeping, nausea, fever, and low blood cell counts. Other side effects may include infertility and kidney problems. When used during pregnancy, it causes birth defects in some animals. Valganciclovir is the L-valyl ester of ganciclovir and works when broken down into ganciclovir by the intestine and liver. Valganciclovir was approved for medical use in 2001. It is on the World Health Organization's List of Essential Medicines. In 2017 a generic version was approved. Valganciclovir is commonly used for treatment of cytomegalovirus (CMV) retinitis (eye infection may cause blindness) in people who have acquired immunodeficiency syndrome (AIDS). Valganciclovir is also used to prevent cytomegalovirus disease in people who have received a heart, kidney, or kidney-pancreas transplant and who have a chance of getting CMV disease. Overall, valganciclovir works by preventing the spread of CMV disease or slowing the growth of CMV.Valganciclovir is used for the prevention of CMV disease in people following kidney transplant (4 months to 16 years of age) and heart transplant (1 month to 16 years of age) at high risk.
ALSO READ : http://www.marketwatch.com/story/valganciclovir-market-size-share-v...
The report demonstrates detail coverage of Valganciclovir industry and main market trends.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares of the leading Valganciclovir by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global Valganciclovir market discussed. Overall, this report covers the historical situation, present status and the future prospects of the global Valganciclovir market for 2016-2026.
Moreover,the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to over 100 countries and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard,while the online market increase. Fortunately, with the development of vaccine and other effort by global governments and orgnizations, the nagetive impact of COVID-19 is
ALSO READ : http://www.marketwatch.com/story/pipeline-tracer-wires-market-resea...
excepted to subside and the global ecnomy is excepted to recover.
Studying and analyzing the impact of Coronavirus COVID-19 on the Valganciclovir industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Powder for Solution
Tablet
Market Segment by Product Application
Adults
Children
Finally, the report provides detailed profile and data information analysis of leading company.
Rakshit Drugs
United Biotech Private Limited
Report Includes:
- xx data tables (appendix tables)
- Overview of global Valganciclovir market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Valganciclovir market
- Profiles of major players in the industry, including Rakshit Drugs, United Biotech Private Limited, , , .....
ALSO READ : http://www.marketwatch.com/story/cenospheres-market-research-report...
Research Objectives
1.To study and analyze the global Valganciclovir consumption (value & volume) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Valganciclovir market by identifying its various subsegments.
3.Focuses on the key global Valganciclovir manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Valganciclovir with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Valganciclovir submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
ALSO READ : http://www.marketwatch.com/story/hollow-fiber-membrane-market-resea...
Table of Contents
Global Valganciclovir Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Valganciclovir Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Valganciclovir Segment by Type
2.1.1 Powder for Solution
2.1.2 Tablet
2.2 Market Analysis by Application
2.2.1 Adults
2.2.2 Children
2.3 Global Valganciclovir Market Comparison by Regions (2016-2026)
2.3.1 Global Valganciclovir Market Size (2016-2026)
2.3.2 North America Valganciclovir Status and Prospect (2016-2026)
2.3.3 Europe Valganciclovir Status and Prospect (2016-2026)
2.3.4 China Valganciclovir Status and Prospect (2016-2026)
2.3.5 Japan Valganciclovir Status and Prospect (2016-2026)
2.3.6 Southeast Asia Valganciclovir Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Valganciclovir Industry Impact
2.5.1 Valganciclovir Business Impact Assessment - Covid-19
2.5.2 Market Trends and Valganciclovir Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
ALSO READ : http://www.marketwatch.com/story/robotic-prosthetics-market-researc...
3 Competition by Manufacturer
3.1 Global Valganciclovir Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Valganciclovir Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Valganciclovir Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Valganciclovir Manufacturer Market Share
3.5 Top 10 Valganciclovir Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Valganciclovir Market
3.7 Key Manufacturers Valganciclovir Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Valganciclovir Industry Key Manufacturers
4.1 Rakshit Drugs
4.1.1 Compan Detail
4.1.2 Rakshit Drugs Valganciclovir Product Introduction, Application and Specification
4.1.3 Rakshit Drugs 138 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Rakshit Drugs News
4.2 United Biotech Private Limited
4.2.1 Compan Detail
4.2.2 United Biotech Private Limited Valganciclovir Product Introduction, Application and Specification
4.2.3 United Biotech Private Limited Valganciclovir Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Rakshit Drugs News
5 Global Valganciclovir Market Segment by Big Type
5.1 Global Valganciclovir Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Valganciclovir Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Valganciclovir Revenue and Market Share by Big Type (2016-2021)
5.2 Powder for Solution Sales Growth Rate and Price
5.2.1 Global Powder for Solution Sales Growth Rate (2016-2021)
5.2.2 Global Powder for Solution Price (2016-2021)
5.3 Tablet Sales Growth Rate and Price
5.3.1 Global Tablet Sales Growth Rate (2016-2021)
5.3.2 Global Tablet Price (2016-2021)
6 Global Valganciclovir Market Segment by Big Application
6.1 Global Valganciclovir Sales Market Share by Big Application (2016-2021)
6.2 Adults Sales Growth Rate (2016-2021)
6.3 Children Sales Growth Rate (2016-2021)
7 Global Valganciclovir Forecast
7.1 Global Valganciclovir Revenue, Sales and Growth Rate (2021-2026)
7.2 Valganciclovir Market Forecast by Regions (2021-2026)
7.2.1 North America Valganciclovir Market Forecast (2021-2026)
7.2.2 Europe Valganciclovir Market Forecast (2021-2026)
7.2.3 China Valganciclovir Market Forecast (2021-2026)
7.2.4 Japan Valganciclovir Market Forecast (2021-2026)
7.2.5 Southeast Asia Valganciclovir Market Forecast (2021-2026)
7.2.6 Other Regions Valganciclovir Market Forecast (2021-2026)
7.3 Valganciclovir Market Forecast by Type (2021-2026)
7.3.1 Global Valganciclovir Sales Forecast by Type (2021-2026)
7.3.2 Global Valganciclovir Market Share Forecast by Type (2021-2026)
7.4 Valganciclovir Market Forecast by Application (2021-2026)
7.4.1 Global Valganciclovir Sales Forecast by Application (2021-2026)
7.4.2 Global Valganciclovir Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Valganciclovir Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Valganciclovir Manufacturing Cost Analysis
9.2 Downstream Market Analysis

....continued

CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105